Vet Lines MSDS BRAVECTO Fluralaner Chewable Tablets for Dogs | Page 8

MATERIAL SAFETY DATA SHEET
Product Name : BRAVECTO Chewable Tablets for Dogs

MATERIAL SAFETY DATA SHEET

Version 1 issued : February , 2015 Page : 8 of 11
Polyethylene glycol was negative in a bacterial mutagenicity study ( Ames ). Results were inconclusive in a bacterial DNA repair study . Glycerin was negative in a bacterial mutagenicity study ( Ames ). Glycerin was positive in chromosome aberration studies in rat bone marrow and sperm cells ; however , it was negative in an occupational cytogenetics chromosome aberration study . Sucrose was negative in a variety of mutagenicity assays . Toxic effects are always dose dependent – and exposure to Polyethylene glycol , Sucrose and Glycerin from the Bravecto chewable tablet is negligible .
CARCINOGENICITY : Sucrose was not carcinogenic in mice and rats exposed to 10 % in the diet for 18 months ; however , sucrose showed tumour promoting activity in mice . Toxic effects are always dose dependent – and exposure to Sucrose from the Bravecto chewable tablet is negligible .
Classification of Hazardous Ingredients
Ingredient
Risk Phrases
No ingredient mentioned in the HSIS Database is present in this product at hazardous concentrations .
MATERIAL SAFETY DATA SHEET Issued by : Intervet Australia Pty Limited ( trading as MSD Animal Health ) Phone : 1 800 033 461 ( Business Hours ) Poisons Information Centre : 13 11 26 from anywhere in Australia , ( 0800 764 766 in New Zealand )